Inflammation is one of the mechanisms leading to AMI,4 high‐sensitivity C‐reactive protein (hs‐CRP) as a biomarker of inflammation has been proven to be an important risk factor for cardiovascular disease,5 It has also been shown to be associated with prognosis in patients with myocardial infarction.6 This evidence concerns the gene CRP and myocardial infarction.